bluebird bio (BLUE)
(Delayed Data from NSDQ)
$1.11 USD
+0.03 (2.78%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.11 0.00 (0.00%) 6:52 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.43 | -5.88% |
Earnings Summary
For their last quarter, bluebird bio (BLUE) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-0.69 per share. This reflects a positive earnings surprise of 4.35%. Look out for BLUE's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.43 per share, reflecting a year-over-year increase of 35.82%.
Earnings History
Price & Consensus
Zacks News for BLUE
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?
BLUE: What are Zacks experts saying now?
Zacks Private Portfolio Services